Abstract:Myostatin (MSTN), previously referred to as growth differentiation factor 8 (GDF8), is a negative regulator of skeletal muscle growth. In accordance with this role, natural mutations that inactivate the gene disrupting the function of the protein are associated with excessive muscle growth and double-muscling phenotype in several mammalian species. Recent studies using transgenic MSTN deficient zebrafish and medaka support the idea that this gene inhibits skeletal muscle growth even in fish. If the atrophic actions of mammalian MSTN are indeed conserved in fish, strategies capable of inhibiting the expression of this gene could be applied to enhance growth performance in livestock production. Gene silencing by RNA interference has emerged as a promising new method of inhibiting the expression of targeted genes and inducing knockdown of associated proteins both in vitro and in vivo. Accordingly, we investigated here whether double-stranded RNA (dsRNA) or different plasmids expressing short-hairpin interfering RNAs (shRNAs) against myostatin and transduced by in vivo electroporation would increase skeletal muscle mass in reared European sea bass. After 7 weeks of intramuscular injections on a weekly basis followed by in vivo electrically mediated dsRNA delivery, no increase in the condition factor (K) of fish was observed as compared to the controls. Analogously, mean body weight and K of sea bass injected with three shRNAs were not higher than those of the control fish. On the other hand, MSTN transcript quantification via real-time RT-PCR revealed a significant inhibition of gene expression in the muscle of the dsRNA-injected fish and in the muscle of fish injected with one of the three tested shRNA-expressing vector constructs. In conclusion, in vivo electric-mediated delivery of dsRNA- or shRNA-expressing vectors against MSTN inhibits MSTN gene expression in adult sea bass muscle, but this is associated with an inconsistent double-muscle phenotype.

Silencing myostatin gene by RNAi in sheep embryos.

Selection of an Effective Small Interference RNA to Silence Myostatin Gene Expression in Sheep Fibroblast Cells

CRISPR/Cas9-mediated sheep MSTN gene knockout and promote sSMSCs differentiation

308 DEVELOPMENT OF TRANSGENIC LIVESTOCK WITH REDUCED MYOSTATIN EXPRESSION USING RNA INTERFERENCE

Transcript characteristic of myostatin in sheep fibroblasts.

The effect of myostatin silencing by lentiviral-mediated RNA interference on goat fetal fibroblasts

Lentiviral-Mediated Silencing of Farnesyl Pyrophosphate Synthase Through RNA Interference in Mice

Generation of Double-Muscled Sheep and Goats by CRISPR /Cas9-Mediated Knockout of the Myostatin Gene

Knockdown of the prion gene expression by RNA interference in bovine fibroblast cells

Effective MSTN Gene Knockout by AdV-Delivered CRISPR/Cas9 in Postnatal Chick Leg Muscle.

Efficient and Specific Generation of MSTN-Edited Hu Sheep Using C-CRISPR

An enzymatic‐histochemical study of the corpus uteri of the mouse

Electroporation Delivery of Cas9 sgRNA Ribonucleoprotein-Mediated Genome Editing in Sheep IVF Zygotes

Disruption of the Myostatin Gene in Porcine Primary Fibroblasts and Embryos Using Zinc-Finger Nucleases

Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System

Comparative analysis of silencing expression of myostatin (MSTN) and its two receptors (ACVR2A and ACVR2B) genes affecting growth traits in knock down chicken

Establishment of a Myostatin Gene-Knockout C2C12 Cell Line and Evaluation of Related Microrna Expression

Inhibition of Myostatin Gene Expression in Skeletal Muscle of Fish by In Vivo Electrically Mediated dsRNA and shRNAi Delivery

[The dry eye. Status determination and prospects].

HMEJ-mediated site-specific integration of a myostatin inhibitor increases skeletal muscle mass in porcine

Efficient modification of the myostatin gene in porcine somatic cells and generation of knockout piglets